Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409

1.

Gene therapy of hemoglobinopathies: progress and future challenges.

Ikawa Y, Miccio A, Magrin E, Kwiatkowski JL, Rivella S, Cavazzana M.

Hum Mol Genet. 2019 Jul 19. pii: ddz172. doi: 10.1093/hmg/ddz172. [Epub ahead of print]

PMID:
31322165
2.

Accurate detection of renal leukemic involvement in children using 3-D computed tomography modeling.

Fujiki T, Nishimura R, Mase S, Kuroda R, Ikawa Y, Araki R, Maeba H, Yachie A.

Pediatr Int. 2019 Jul;61(7):679-687. doi: 10.1111/ped.13907.

PMID:
31173414
3.

Oligomerization of a modular ribozyme assembly of which is controlled by a programmable RNA-RNA interface between two structural modules.

Tsuruga R, Uehara N, Suzuki Y, Furuta H, Sugiyama H, Endo M, Matsumura S, Ikawa Y.

J Biosci Bioeng. 2019 May 17. pii: S1389-1723(19)30252-X. doi: 10.1016/j.jbiosc.2019.04.003. [Epub ahead of print]

PMID:
31109874
4.

Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.

Jinkawa A, Shimizu M, Nishida K, Kaneko S, Usami M, Sakumura N, Irabu H, Takakuwa M, Inoue N, Mizuta M, Ikawa Y, Fujita S, Yachie A.

Cytokine. 2019 Jul;119:52-56. doi: 10.1016/j.cyto.2019.03.001. Epub 2019 Mar 14.

PMID:
30877950
5.

Massive intestinal liquid retention in a case of severe heat stroke.

Sato A, Ikawa Y, Inoue N, Kuroda M, Shimizu M, Yachie A.

J Paediatr Child Health. 2019 Feb;55(2):248-249. doi: 10.1111/jpc.14343. No abstract available.

PMID:
30746885
6.

A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.

Mizumaki K, Maeda S, Ikawa Y, Matsushita T, Takehara K, Hamaguchi Y.

J Dermatol. 2019 Jul;46(7):e251-e253. doi: 10.1111/1346-8138.14790. Epub 2019 Jan 28. No abstract available.

PMID:
30690762
7.

Modular Architecture of Bacterial RNase P Ribozymes as a Structural Platform for RNA Nanostructure Design.

Nozawa Y, Hagihara M, Matsumura S, Ikawa Y.

Chimia (Aarau). 2018 Dec 19;72(12):882-887. doi: 10.2533/chimia.2018.882.

PMID:
30648955
8.

Nonallergic cutaneous pigmentation is commonly observed after methotrexate administration.

Ikawa Y, Nishimura R, Araki R, Noguchi K, Fukuda M, Fujiki T, Kuroda R, Mase S, Maeba H, Yachie A.

J Oncol Pharm Pract. 2019 Apr;25(3):769-771. doi: 10.1177/1078155218815557. Epub 2018 Nov 30. No abstract available.

PMID:
30501379
9.

Effects of molecular crowding on a bimolecular group I ribozyme and its derivative that self-assembles to form ribozyme oligomers.

Rahman MM, Matsumura S, Ikawa Y.

Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):136-141. doi: 10.1016/j.bbrc.2018.10.188. Epub 2018 Nov 8.

PMID:
30415779
10.

Distinct modulation of group I ribozyme activity among stereoisomers of a synthetic pentamine with structural constraints.

Gulshan MA, Tsuji K, Matsumura S, Higuchi T, Umezawa N, Ikawa Y.

Biochem Biophys Res Commun. 2018 Oct 12;504(4):698-703. doi: 10.1016/j.bbrc.2018.09.015. Epub 2018 Sep 10.

PMID:
30213632
11.

Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis.

Murata A, Watanabe S, Ikawa Y, Saeki K, Yamamura K, Matsuoka H, Tanimura K, Tambo Y, Kasahara K.

J Dermatol. 2019 Apr;46(4):e118-e119. doi: 10.1111/1346-8138.14641. Epub 2018 Sep 11. No abstract available.

PMID:
30204265
12.

Oligomerization of a Bimolecular Ribozyme Modestly Rescues its Structural Defects that Disturb Interdomain Assembly to Form the Catalytic Site.

Rahman MM, Matsumura S, Ikawa Y.

J Mol Evol. 2018 Aug;86(7):431-442. doi: 10.1007/s00239-018-9862-8. Epub 2018 Aug 14.

PMID:
30105586
13.

Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.

Ikawa Y, Fujiki T, Nishimura R, Noguchi K, Koshino E, Fujiki A, Fukuda M, Kuroda R, Mase S, Araki R, Maeba H, Shiraki K, Yachie A.

J Infect Chemother. 2019 Jan;25(1):65-67. doi: 10.1016/j.jiac.2018.07.004. Epub 2018 Jul 29.

PMID:
30064949
14.

Comparative study of polyethylene polyamines as activator molecules for a structurally unstable group I ribozyme.

Gulshan MA, Matsumura S, Higuchi T, Umezawa N, Ikawa Y.

Biosci Biotechnol Biochem. 2018 Aug;82(8):1404-1407. doi: 10.1080/09168451.2018.1465811. Epub 2018 Apr 26.

PMID:
29699448
15.

Recognition of cyclic-di-GMP by a riboswitch conducts translational repression through masking the ribosome-binding site distant from the aptamer domain.

Inuzuka S, Kakizawa H, Nishimura KI, Naito T, Miyazaki K, Furuta H, Matsumura S, Ikawa Y.

Genes Cells. 2018 Jun;23(6):435-447. doi: 10.1111/gtc.12586. Epub 2018 Apr 25.

16.

A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).

Araki R, Nishimura R, Kuroda R, Fujiki T, Mase S, Noguchi K, Ikawa Y, Maeba H, Yachie A.

Int J Hematol. 2018 Aug;108(2):151-160. doi: 10.1007/s12185-018-2454-y. Epub 2018 Apr 16.

PMID:
29663189
17.

Head position affects the direction of occlusal force during tapping movement.

Nakamura K, Minami I, Wada J, Ikawa Y, Wakabayashi N.

J Oral Rehabil. 2018 May;45(5):363-370. doi: 10.1111/joor.12618. Epub 2018 Mar 6.

PMID:
29446484
18.

Deep spontaneous molecular remission in a patient with congenital acute myeloid leukemia expressing a novel MOZ-p300 fusion transcript.

Ikawa Y, Nishimura R, Maeba H, Fujiki T, Kuroda R, Noguchi K, Fukuda M, Mase S, Araki R, Mitani Y, Sato T, Terui K, Ito E, Kitabayashi I, Yachie A.

Leuk Lymphoma. 2018 Oct;59(10):2497-2499. doi: 10.1080/10428194.2018.1434885. Epub 2018 Feb 12. No abstract available.

PMID:
29431567
19.

Concomitant Regulation by a LacI-Type Transcriptional Repressor XylR on Genes Involved in Xylan and Xylose Metabolism and the Type III Secretion System in Rice Pathogen Xanthomonas oryzae pv. oryzae.

Ikawa Y, Ohnishi S, Shoji A, Furutani A, Tsuge S.

Mol Plant Microbe Interact. 2018 Jun;31(6):605-613. doi: 10.1094/MPMI-11-17-0277-R. Epub 2018 Apr 3.

PMID:
29360015
20.

Biogenic triamine and tetraamine activate core catalytic ability of Tetrahymena group I ribozyme in the absence of its large activator module.

Gulshan MA, Rahman MM, Matsumura S, Higuchi T, Umezawa N, Ikawa Y.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):594-600. doi: 10.1016/j.bbrc.2018.01.085. Epub 2018 Jan 12.

PMID:
29339152
21.
22.

Hearing impairment accompanied with low-tone tinnitus during all trans retinoic acid containing chemotherapy.

Fujiki T, Nishimura R, Ikawa Y, Noguchi K, Mase S, Kuroda R, Araki R, Maeba H, Yachie A.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26864. Epub 2017 Oct 28. No abstract available.

PMID:
29080387
23.

Rational Engineering of a Modular Group I Ribozyme to Control Its Activity by Self-Dimerization.

Tanaka T, Ikawa Y, Matsumura S.

Methods Mol Biol. 2017;1632:325-340. doi: 10.1007/978-1-4939-7138-1_21.

PMID:
28730449
24.

Extracranial Carotid Aneurysm in Takayasu Arteritis.

Shimizu M, Shirahashi T, Mizuta M, Ikawa Y, Yachie A.

J Clin Rheumatol. 2017 Aug;23(5):289. doi: 10.1097/RHU.0000000000000549. No abstract available.

PMID:
28700525
25.

Refractory cutaneous polyarteritis nodosa: Successful treatment with etanercept.

Inoue N, Shimizu M, Mizuta M, Ikawa Y, Yachie A.

Pediatr Int. 2017 Jun;59(6):751-752. doi: 10.1111/ped.13283. No abstract available.

PMID:
28626974
26.

Heterodimerization of Group I Ribozymes Enabling Exon Recombination through Pairs of Cooperative trans-Splicing Reactions.

Tanaka T, Hirata Y, Tominaga Y, Furuta H, Matsumura S, Ikawa Y.

Chembiochem. 2017 Aug 17;18(16):1659-1667. doi: 10.1002/cbic.201700053. Epub 2017 Jul 4.

PMID:
28556398
27.

FDG-PET in macrophage activation syndrome associated with systemic juvenile idiopathic arthritis.

Shimizu M, Ikawa Y, Mizuta M, Takakura M, Inoue N, Nishimura R, Yachie A.

Pediatr Int. 2017 Apr;59(4):509-511. doi: 10.1111/ped.13238.

PMID:
28401744
28.

A Wnt5 Activity Asymmetry and Intercellular Signaling via PCP Proteins Polarize Node Cells for Left-Right Symmetry Breaking.

Minegishi K, Hashimoto M, Ajima R, Takaoka K, Shinohara K, Ikawa Y, Nishimura H, McMahon AP, Willert K, Okada Y, Sasaki H, Shi D, Fujimori T, Ohtsuka T, Igarashi Y, Yamaguchi TP, Shimono A, Shiratori H, Hamada H.

Dev Cell. 2017 Mar 13;40(5):439-452.e4. doi: 10.1016/j.devcel.2017.02.010.

29.

Programmable formation of catalytic RNA triangles and squares by assembling modular RNA enzymes.

Oi H, Fujita D, Suzuki Y, Sugiyama H, Endo M, Matsumura S, Ikawa Y.

J Biochem. 2017 May 1;161(5):451-462. doi: 10.1093/jb/mvw093.

PMID:
28096453
30.

Use of a Fluorescent Aptamer RNA as an Exonic Sequence to Analyze Self-Splicing Ability of aGroup I Intron from Structured RNAs.

Furukawa A, Tanaka T, Furuta H, Matsumura S, Ikawa Y.

Biology (Basel). 2016 Nov 17;5(4). pii: E43.

31.

Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.

Ikawa Y, Hamaguchi Y, Mugii N, Matsushita T, Takehara K.

Mod Rheumatol. 2017 Jul;27(4):614-617. doi: 10.1080/14397595.2016.1250332. Epub 2016 Nov 14.

PMID:
27830961
32.
33.

Neonatal McCune-Albright Syndrome with Giant Cell Hepatitis.

Ikawa Y, Yachi Y, Inoue N, Kato A, Okajima M, Yachie A.

J Pediatr. 2016 Nov;178:298. doi: 10.1016/j.jpeds.2016.08.009. Epub 2016 Aug 31. No abstract available.

PMID:
27592093
34.

Cover Image: Life-threatening complications of jellyfish Chrysaora pacifica stings in a 5-year-old child.

Ikawa Y, Fujita N, Yachi Y, Inoue N, Kato A, Kuroda M, Yachie A.

Br J Dermatol. 2016 Oct;175(4):837-8. doi: 10.1111/bjd.14856. No abstract available.

PMID:
27650747
35.

Immunostaining of Sulfatide-Storing Macrophages in Gallbladder of a Patient With Metachromatic Leukodystrophy.

Inoue N, Ikawa Y, Sato A, Yokoi A, Kuroda M, Nomura K, Sakai S, Tajima H, Ikeda H, Ebisu H, Kawasaki H, Ohta T, Yachie A.

Pediatr Neurol. 2016 Nov;64:e3-e4. doi: 10.1016/j.pediatrneurol.2016.08.006. Epub 2016 Aug 16. No abstract available.

PMID:
27640320
36.

Minimal contribution of severe hypertriglyceridemia in L-asparaginase-associated pancreatitis developed in a child with acute lymphocytic leukemia.

Goto Y, Nishimura R, Nohara A, Mase S, Fujiki T, Irabu H, Kuroda R, Araki R, Ikawa Y, Maeba H, Yachie A.

Rinsho Ketsueki. 2016 Aug;57(8):994-8. doi: 10.11406/rinketsu.57.994. Japanese.

PMID:
27599414
37.

Effects of citalopram on jaw-closing muscle activity during sleep and wakefulness in mice.

Ikawa Y, Mochizuki A, Katayama K, Kato T, Ikeda M, Abe Y, Nakamura S, Nakayama K, Wakabayashi N, Baba K, Inoue T.

Neurosci Res. 2016 Dec;113:48-55. doi: 10.1016/j.neures.2016.07.004. Epub 2016 Jul 21.

PMID:
27453206
38.

Tecto-GIRz: Engineered Group I Ribozyme the Catalytic Ability of Which Can Be Controlled by Self-Dimerization.

Tanaka T, Matsumura S, Furuta H, Ikawa Y.

Chembiochem. 2016 Aug 3;17(15):1448-55. doi: 10.1002/cbic.201600190. Epub 2016 Jun 30.

PMID:
27247120
39.
40.

The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.

Nakao M, Asano Y, Nakamura K, Shida R, Takahashi T, Yoshizaki A, Mitsui A, Shibata S, Araki M, Watanabe R, Ikawa Y, Toyoda C, Oka H, Sato S.

Eur J Dermatol. 2016 Aug 1;26(4):404-5. doi: 10.1684/ejd.2016.2781. No abstract available.

PMID:
27086491
41.

Pathognomonic serum cytokine profiles identify life-threatening langerhans cell histiocytosis.

Ikawa Y, Nishimura R, Araki R, Noguchi K, Muraoka M, Fukuda M, Fujiki T, Kuroda R, Mase S, Maeba H, Nomura K, Yachie A.

Br J Haematol. 2017 Feb;176(3):495-497. doi: 10.1111/bjh.13970. Epub 2016 Apr 7. No abstract available.

PMID:
27062281
42.

Mutational analysis of structural elements in a class-I cyclic di-GMP riboswitch to elucidate its regulatory mechanism.

Inuzuka S, Nishimura K, Kakizawa H, Fujita Y, Furuta H, Matsumura S, Ikawa Y.

J Biochem. 2016 Sep;160(3):153-62. doi: 10.1093/jb/mvw026. Epub 2016 Mar 31.

PMID:
27033943
43.

The quantitative regulation of the hrp regulator HrpX is involved in sugar-source-dependent hrp gene expression in Xanthomonas oryzae pv. oryzae.

Ikawa Y, Tsuge S.

FEMS Microbiol Lett. 2016 May;363(10). pii: fnw071. doi: 10.1093/femsle/fnw071. Epub 2016 Mar 27.

PMID:
27020414
44.

Leopard skin appearance of cutaneous polyarteritis nodosa on 18Ffluorodeoxyglucose positron emission tomography.

Shimizu M, Inoue N, Mizuta M, Ikawa Y, Yachie A.

Rheumatology (Oxford). 2016 Jun;55(6):1090. doi: 10.1093/rheumatology/kew065. Epub 2016 Mar 22. No abstract available.

PMID:
27009824
45.

Optimization of RNA-based c-di-GMP fluorescent sensors through tuning their structural modules.

Inuzuka S, Matsumura S, Ikawa Y.

J Biosci Bioeng. 2016 Aug;122(2):183-7. doi: 10.1016/j.jbiosc.2016.01.011. Epub 2016 Mar 9.

PMID:
26968125
46.

Characterization of an RNA receptor motif that recognizes a GCGA tetraloop.

Furukawa A, Maejima T, Matsumura S, Ikawa Y.

Biosci Biotechnol Biochem. 2016 Jul;80(7):1386-9. doi: 10.1080/09168451.2016.1156483. Epub 2016 Mar 11.

PMID:
26967268
47.

Prototheca miyajii sp. nov., isolated from a patient with systemic protothecosis.

Masuda M, Hirose N, Ishikawa T, Ikawa Y, Nishimura K.

Int J Syst Evol Microbiol. 2016 Mar;66(3):1510-1520. doi: 10.1099/ijsem.0.000911. Epub 2016 Jan 19.

PMID:
26791403
48.

Successful treatment of exertional heat stroke using continuous plasma diafiltration.

Inoue N, Sato A, Ikawa Y, Shimizu M, Okajima M, Taniguchi T, Yachie A.

J Clin Apher. 2016 Oct;31(5):490-2. doi: 10.1002/jca.21439. Epub 2015 Nov 17.

PMID:
26575209
49.

Dark/light transition and vigilance states modulate jaw-closing muscle activity level in mice.

Katayama K, Mochizuki A, Kato T, Ikeda M, Ikawa Y, Nakamura S, Nakayama K, Wakabayashi N, Baba K, Inoue T.

Neurosci Res. 2015 Dec;101:24-31. doi: 10.1016/j.neures.2015.07.004. Epub 2015 Jul 16.

PMID:
26188127
50.

Artificial ligase ribozymes isolated by a "design and selection" strategy.

Matsumura S, Ikawa Y.

Methods Mol Biol. 2015;1316:113-25. doi: 10.1007/978-1-4939-2730-2_10.

PMID:
25967057

Supplemental Content

Support Center